The University of Chicago Header Logo

Connection

Hedy Kindler to Class I Phosphatidylinositol 3-Kinases

Back to Details
This is a "connection" page, showing publications Hedy Kindler has written about Class I Phosphatidylinositol 3-Kinases.
Hedy Kindler
Connection Strength
0.130
Class I Phosphatidylinositol 3-Kinases
  1. Phase I Study of Apitolisib (GDC-0980), Dual Phosphatidylinositol-3-Kinase and Mammalian Target of Rapamycin Kinase Inhibitor, in Patients with Advanced Solid Tumors. Clin Cancer Res. 2016 06 15; 22(12):2874-84.
    View in: PubMed
    Score: 0.130
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.